References
- CowlesBJLisdexamfetamine for treatment of attention-deficit/hyperactivity disorderAnn Pharmacother200943466967619318601
- BiedermanJBoellnerSWChildressALopezFAKrishnanSZhangYLisdexamfetamine dimesylate and mixed amphetamine salts extended-release in children with ADHD: A double-blind, placebo-controlled, crossover analog classroom studyBiol Psychiatry200762997097617631866
- ErmerJHomolkaRMartinPBuckwalterMPurkayasthaJRoeschBLisdexamfetamine dimesylate: Linear dose-proportionality, low intersubject and intrasubject variability, and safety in an open-label single-dose pharmacokinetic study in healthy adult volunteersJ Clin Pharmacol2192010 [Epub ahead of print]
- Institute of Laboratory Animal ResourcesAnimal environment, housing, and managementGuide for the Care and Use of Laboratory AnimalsWashington, DCNational Academies Press19962155
- UsanskyHHHuPSinkoPJDifferential roles of P-glycoprotein, multidrug resistance-associated protein 2, and CYP3A on saquinavir oral absorption in Sprague-Dawley ratsDrug Metab Dispos200836586386918256206
- SalphatiLChildersKPanLTsutsuiKTakahashiLEvaluation of a single-pass intestinal-perfusion method in rat for the prediction of absorption in manJ Pharm Pharmacol20015371007101311480535
- BretschneiderBBrandschMNeubertRIntestinal transport of ß-lactam antibiotics: Analysis of the affinity at the H+/peptide symporter (PEPT1), the uptake into Caco-2 cell monolayers and the transepithelial fluxPharm Res199916155619950279
- ShimizuRSukegawaTTsudaYItohTQuantitative prediction of oral absorption of PEPT1 substrates based on in vitro uptake into Caco-2 cellsInt J Pharm20083541–210411018276092
- HayeshiRHilgendorfCArturssonPComparison of drug transporter gene expression and functionality in Caco-2 cells from 10 different laboratoriesEur J Pharm Sci200835538339618782614
- HanH-KRhieJKOhD-MCHO/hPEPT1 cells overexpressing the human peptide transporter (hPEPT1) as an alternative in vitro model for peptidomimetic drugsJ Pharm Sci199988334735010052994
- MacDonaldJMXuASLHiroshiKEx vivo maintenance of cells from the liver lineageLanzaWLLangerRVacantiJMethods of Tissue EngineeringSan Diego, CAAcademic Press2001
- ShojaeiAErmerJCKrishnanSLisdexamfetamine dimesylate as a treatment for ADHD: Dosage formulation and pH effectsPoster presented at: 160th Annual Meeting of the American Psychiatric AssociationMay 19–24, 2007San Diego, CA Poster NR 740.
- ShenHSmithDEBrosiusFCIIIDevelopmental expression of PEPT1 and PEPT2 in rat small intestine, colon, and kidneyPediatr Res200149678979511385139
- YamashitaSHattoriEShimadaANew methods to evaluate intestinal drug absorption mediated by oligopeptide transporter from in vitro study using Caco-2 cellsDrug Metab Pharmacokinet200217540841515618692
- ChuX-YSánchez-CastañoGPHigakiKOhD-MHsuC-PAmidonGLCorrelation between epithelial cell permeability of cephalexin and expression of intestinal oligopeptide transporterJ Pharmacol Exp Ther2001299257558211602669
- HilgendorfCAhlinGSeithelAArturssonPUngellA-LKarlssonJExpression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell linesDrug Metab Dispos20073581333134017496207
- MitsuokaKKatoYKuboYTsujiAFunctional expression of stereoselective metabolism of cephalexin by exogenous transfection of oligopeptide transporter PEPT1Drug Metab Dispos200735335636217142565
- BrandschMKnütterILeibachFHThe intestinal H+/peptide symporter PEPT1: Structure-affinity relationshipsEur J Pharm Sci2004211536014706811
- DanielHMolecular and integrative physiology of intestinal peptide transportAnnu Rev Physiol20046636138414977407
- Keflex® (Package insert)Germantown, MDMiddlebrook Pharmaceuticals, Inc.2006
- KrishnanSZhangYRelative bioavailability of lisdexamfetamine 70-mg capsules in fasted and fed healthy adult volunteers and in solution: A single-dose, crossover pharmacokinetic studyJ Clin Phar-macol2008483293302
- Vyvanse® (Package insert)Wayne, PAShire US Inc.2009
- JasinskiDRKrishnanSHuman pharmacology of intravenous lisdexamfetamine dimesylate: Abuse liability in adult stimulant abusersJ Psychopharmacol200923441041818635707
- ErmerJDennisKHaffeyMPharmacokinetics of intranasal versus oral administration of lisdexamfetamine dimesylate in healthy adultsPoster presented at: American Psychiatric Association ’s 162nd annual meetingMay 16–21, 2009San Francisco, CA
- HaffeyMBBuckwalterMZhangPEffects of omeprazole on the pharmacokinetic profiles of lisdexamfetamine dimesylate and mixed amphetamine salts extended release in adultsPostgrad Med20091215111919820270